Form 4: Madrigal Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

Rebecca Taub, a Madrigal Pharmaceuticals executive, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On January 24, 2025, Rebecca Taub, the President of R&D and CMO of Madrigal Pharmaceuticals, sold 648 shares of common stock at a price of $335.24 per share.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• Following the transaction, Taub directly owns 456,662 shares of Madrigal Pharmaceuticals common stock.
• Taub also indirectly owns 655,540 shares through SQN LLC, where she and her spouse are managing members.
• Taub disclaims beneficial ownership of the shares held by SQN LLC except to the extent of her pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to an executive's stock sale to cover tax obligations. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates